Tafenoquine-Based Combination Therapies: A Step Toward Babesiosis Elimination-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tafenoquine-Based Combination Therapies: A Step Toward Babesiosis Elimination

Published:2024-03-13 Issue:5 Volume:229 Page:1599-1600
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Liu Mingming¹²,Galon Eloiza May²³,Ji Shengwei²⁴,Xuan Xuenan²

Affiliation:

1. School of Basic Medicine, Hubei University of Arts and Science , Xiangyang , China

2. National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine , Obihiro , Japan

3. College of Veterinary Medicine and Biomedical Sciences, Cavite State University , Indang , Philippines

4. Department of Veterinary Medicine, Agriculture College of Yanbian University , Yanji , China

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiae083/56965285/jiae083.pdf

Reference10 articles.

1. Tafenoquine-atovaquone combination achieves radical cure and confers sterile immunity in experimental models of human babesiosis;Vydyam;J Infect Dis,2024

2. Could the drug tafenoquine revolutionize treatment of Babesia microti infection?;Mordue;J Infect Dis,2019

3. Tafenoquine is a promising drug candidate for the treatment of babesiosis;Liu;Antimicrob Agents Chemother,2021

4. Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone;Marcos;IDCases,2022

5. Broad antimicrobial resistance in a case of relapsing babesiosis successfully treated with tafenoquine;Rogers;Clin Infect Dis,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Planned Trial to Evaluate the Safety and Efficacy of Tafenoquine + Atovaquone/Azithromycin in Hospitalized Patients With Babesiosis;The Journal of Infectious Diseases;2024-05-07

2. Response to the Letter by Liu and Colleagues;The Journal of Infectious Diseases;2024-03-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3